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Background: Hypovitaminosis D is a common condition among elderly individuals in temperate-climate countries,
with a clear seasonal variation on 25 hydroxyvitamin D [(25(OH)D] levels, increasing after summer and decreasing
after winter, but there are few data from sunny countries such as Brazil. We aimed to evaluate 25-hydroxyvitamin D
concentrations and its determining factors, in individuals in the city of São Paulo belonging to different age groups
and presenting different sun exposure habits.
Methods: 591 people were included as follows: 177 were living in institutions (NURSING HOMES, NH, 76.2 ±
9.0 years), 243 were individuals from the community (COMMUNITY DWELLINGS, CD, 79.6 ± 5.3 years), 99 were
enrolled in physical activity program designed for the elderly (PHYSICAL ACTIVITY, PA, 67.6 ± 5.4 years) and 72 were
young (YOUNG, 23.9 ± 2.8 years). Ionized calcium, PTH, 25(OH)D, creatinine and albumin were evaluated. ANOVA,
Mann–Whitney and Kruskal Wallis tests, Pearson Linear Correlation and Multiple Regression were used in the
statistical analysis.
Results: 25(OH)D mean values during winter for the different groups were 36.1 ± 21.2 nmol/L (NH), 44.1 ±
24.0 nmol/L (CD), 78.9 ± 30.9 nmol/L (PA) and 69.6 ± 26.2 nmol/L (YOUNG) (p < 0.001) while during summer they
were 42.1 ± 25.9 nmol/L, 59.1 ± 29.6 nmol/L, 91.6 ± 31.7 nmol/L and 103.6 ± 29.3 nmol/L, respectively (p < 0.001). The
equation which predicts PTH values based on 25(OH)D concentration is PTH = 10 + 104.24.e-(vitD-12.5)/62.36 and the
25(OH)D value above which correlation with PTH is lost is 75.0 nmol/L. In a multiple regression analysis having 25
(OH)D concentration as the depending variable, the determining factors were PTH, ionized calcium and month of
the year (p < 0.05).
Conclusions: Much lower 25(OH)D values were found for the older individuals when compared to younger
individuals. This finding is possibly due to age and habit-related differences in sunlight exposure. The existence of
seasonal effects on 25(OH)D concentration throughout the year was evident for all the groups studied, except for
the nursing home group. According to our data, PTH values tend to plateau above 75 nmol/L.
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Hypovitaminosis D is well documented, mainly among
elderly populations in countries from the northern hemi-
sphere [1-4]. For the elderly, hypovitaminosis D stimu-
lates the parathyroid gland, both directly and indirectly,
leading to secondary hyperparathyroidism, bringing con-
sequences such as bone mass loss and an increased risk
for fractures [3]. For the young population this correlation
is not clear. The concentrations of 25-hydroxyvitamin D
[25(OH)D] are influenced by several factors, such as the
age, skin tone, latitude, time of the day, season, the wea-
ther and many others. However, some authors evidenced
that, different from what is expected, people from south-
ern European countries have lower concentrations of 25
(OH)D than people from northern countries [1,5]. These
data suggest that habit-related factors also influence 25
(OH)D concentrations and these have not been investi-
gated in countries where sunlight is abundant, such as
Brazil.
This study was named SPADES (The São PAulo
Vitamin D Evaluation Study) and its main objective was
to recognize the factors that contribute to determining
blood 25(OH)D concentrations in four different popula-
tion groups in the city of São Paulo, Brazil (23°34’S, sub-
tropical weather).
Methods
Subjects
The study protocol was previously approved by the
UNIFESP Ethics Committee and all volunteers gave
written informed consent.
The cross-sectional study SPADES aimed at analyzing
data from different age groups in the population and
also groups that have distinct sunlight exposure habits
in the city of São Paulo. All the individual population
groups reported here have already had their results pub-
lished elsewhere and the objective of the present study is
to evaluate all the groups together. The data were
obtained in the same city and the same method was
used for measuring 25(OH)D [6-10].
The first population studied was called NURSING
HOMES (NH) and it was composed of individuals who
live in two nursing homes in the city of São Paulo.
Mostly these individuals are from low income families
that have little access to health services and for this
reason their health conditions were generally poor. Indi-
viduals showing creatinine values above 2.0 mg/dL, hy-
percalcemia, hypocalcemia and those who were confined
to a bed were excluded from the study. The final sample
was represented by 177 individuals, ages varying from 60
to 100 years. Ethnic distribution: 90.9% white and 9.1%
black. Blood samples were drawn in April (fall, 37.3% of
individuals) and July (winter, 62.7% of individuals) of
2001 [6,7].The second population was called COMMUNITY
DWELLINGS (CD) and it originated from a cohort
study (EPIDOSO) developed with people from the dis-
trict around UNIFESP (Universidade Federal de São
Paulo), one of the 55 districts that compose the city of
São Paulo. This region is predominantly composed by a
Caucasian middle class population. We analyzed the
data from 250 individuals, evaluated in 2001, ten years
after the beginning of the study. From those, seven were
excluded from the study (one for showing creatinine
levels above 2.0 mg/dL and six for showing hypercalce-
mia). The final population studied was composed by 243
individuals, ages varying from 61 to 97 years [6-8]. Eth-
nic distribution: 94.6% white and 5.4% black. In this
group, 35.0% of the individuals had their blood samples
collected during summer/fall, while 65.0% had them col-
lected during winter/spring.
The third population was called PHYSICAL ACTIV-
ITY (PA) and was composed of 101 individuals (54
women and 47 men), enrolled in a physical activity pro-
gram destined to the elderly [9]. Each volunteer had a
blood sample collected in two different moments in
2002: one in June (winter) and one in December (summer).
Two patients were excluded from the initial group: one
for presenting primary hyperparathyroidism (PTH
163 pg/mL and ionized calcium 1.56 mM) and the other
for presenting 25(OH)D level much higher than normal
(280 nmol/L). The final population studied was composed
of 99 people and from those, 88 had the second blood
sample collected (88.9% of the initial population). Ages
varied from 55 to 83 years. Ethnic distribution: 60.6%
white, 19.2% Asian, 12.1% black and 8.1% native.
The fourth population was designated YOUNG and
was composed of 72 individuals, age varying from 17 to
35 years. Ethnic distribution: 75% white, 19.4% Asian
and 5.6% black. The blood samples were obtained be-
tween August 2002 and February 2003 [10]. In this
group, 51.4% of the individuals had their blood sample
collected in months corresponding to summer/fall and
48.6% in months corresponding to winter/spring.
The final population of the SPADES study was com-
posed of 591 individuals.
Methods
The blood samples were taken after an eight-hour fast.
Ionized calcium, creatinine, albumin, 25(OH)D and in-
tact parathyroid hormone (PTH) were measured. All
serum samples were collected into refrigerated tubes,
processed in refrigerated centrifuges, and frozen at −20°C
until measured. The ionized calcium was measured after
centrifugation.
Creatinine and albumin were measured by an automatic
colorimetric method (Modular Roche, São Paulo, Brazil).
The ionized calcium was measured using a specific ion-
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PTH (parathyroid hormone) was measured by an
immunofluorimetric in house method (IFMA, VR: 10–
55 pg/mL) [11]. The creatinine clearance was calculated
by the Cockroft-Gault formula [12]. Reference values for
these methods are presented in Table 1.
The 25(OH)D concentrations were determined by an
immunoradiometric assay (Nichols Institute Diagnostics,
San Juan Capristrano, CA, USA). Intra-assay coefficient of
variation was 4.8%, and inter-assay coefficient of variation
was 16.0% for the lowest values (mean: 35.5 nmol/L) and
3.0% for the highest control (mean: 154.0 nmol/L).
To certify that the radiation conditions were similar
through the years, we compared ultraviolet radiationTable 1 Mean ± standard deviation and reference values (RV)
to the gender and group of origin
NH
(N = 177)
M = 49 W = 128
Age (years) 76.2 ± 9.0
Male 73.8 ± 8.8
Female 77.7 ± 8.9
BMI (RV: 19.0-25.0 kg/m2) 26.3 ± 5.6
Male 25.2 ± 4.9
Female 26.8 ± 5.9
Albumin (RV: 3.5-5.0 g/L) 3.7 ± 0.4
Male 3.6 ± 0.4
Female 3.7 ± 0.4
Creatinine (RV: 0.6-1.5 mg/dL) 1.04 ± 0.3
Male 1.15 ± 0.2£
Female 1.00 ± 0.2£
ClearCrea (RV: 70.0-110.0 mg/dL) 49.7 ± 23.2
Male 56.6 ± 23.2£
Female 47.1 ± 22.7£
Ionized Calcium (RV: 1.12-1.40 mM) 1.28 ± 0.04
Male 1.28 ± 0.10
Female 1.29 ± 0.10
PTH (RV: 10.0-55.0 pg/mL)# 85.0 ± 55.8
Male 85.0 ± 58.2
Female 84.8 ± 55.1
25(OH)D (RV: >75.0 nmol/L)# 37.6 ± 29.9
Male 47.1 ± 20.8£
Female 33.9 ± 32.1£
M =men W = women.
£ significant difference (p < 0.05) in relation to gender inside each group.
* significant difference (p < 0.05) in relation to NURSING HOMES (NH).
Ŧ significant difference (p < 0.05) in relation to COMMUNITY DWELLINGS (CD).
a significant difference (p < 0.05) in relation to YOUNG .
b significant difference (p < 0.05) in relation to PHYSICAL ACTIVITY (PA).
# Non-parametric analysis (Kruskal-Wallis e Wilcoxon tests).
Other variables (One-Way Anova and Scheffé Post Hoc).during 4 consecutive years, and the UV year-pattern was
repetitive (p = 0,444, unpublished data).
The exponential formula that predicts PTH values
from 25(OH)D was created using the software Origin
5.0 (Microcal Inc, Northampton, Massachusetts, USA).
This same program was used for generating Figure 1.
Statistical analysis
The Mann–Whitney test was used to evaluate the differ-
ences between men and women, and ANOVA and
Kruskal Wallis test were used to check for the difference
between the groups according to their origin. The cor-
relation between 25(OH)D and PTH with the other
quantitative variables was evaluated through the Pearsonfor the variables studied and its comparison, according
CD PA Young
(N = 243) (N = 99) (N = 72)
M = 75 W= 168 M = 47 W= 52 M = 32 W= 40
79.6 ± 5.3*b 67.6 ± 5.4* Ŧa 23.9 ± 2.8*Ŧb
79.4 ± 4.4*ab 67.8 ± 4.9*Ŧa 23.8 ± 2.7*Ŧb
79.7 ± 5.6a 67.4 ± 5.9*Ŧa 23.9 ± 2.9*Ŧb
26.7 ± 4.3 27.2 ± 4.4a 22.4 ± 3.0*Ŧ
25.8 ± 3.4£a 28.1 ± 4.0£a 23.1 ± 2.3*£
27.2 ± 4.6£a 27.6 ± 4.7£a 21.9 ± 3.4£*Ŧ
4.0 ± 0.3* 4.0 ± 0.2*Ŧ 4.7 ± 0.5*Ŧb
4.1 ± 0.2*a 4.1 ± 0.2*a 5.0 ± 0.3£Ŧ*
4.0 ± 0.3*a 4.0 ± 0.2*a 4.5 ± 0.4£Ŧ*
0.95 ± 0.2*a 0.98 ± 0.1 1.07 ± 0.2
1.16 ± 0.2£ 1.07 ± 0.1£a 1.20 ± 0.1£
0.85 ± 0.1£* 0.89 ± 0.1£* 0.96 ± 0.1£Ŧ
53.8 ± 15.2 68.5 ± 19.7*Ŧa 88.5 ± 20.8*Ŧ
54.6 ± 17.0£ 70.2 ± 17.7*Ŧa 96.5 ± 13.8£*Ŧ
48.5 ± 23.3£ 66.9 ± 21.5*Ŧa 82.2 ± 23.3£*Ŧ
1.25 ± 0.05* 1.31 ± 0.04*Ŧ 1.31 ± 0.05*Ŧ
1.26 ± 0.10* 1.31 ± 0.03*Ŧ 1.33 ± 0.10£*Ŧ
1.25 ± 0.10* 1.32 ± 0.04*Ŧ 1.29 ± 0.10£*Ŧ
73.8 ± 56.6ab 25.0 ± 12.3*Ŧ 26.4 ± 15.4*Ŧ
78.0 ± 81.7 26.1 ± 15.7*Ŧ 26.8 ± 17.8*Ŧ
71.8 ± 39.8* 23.6 ± 9.5*Ŧ 26.1 ± 13.2*Ŧ
49.5 ± 27.7*ab 78.9 ± 30.9*Ŧ 86.3 ± 34.8*Ŧ
59.4 ± 30.9£ 81.2 ± 30.1*Ŧ 94.3 ± 38.2*Ŧ
45.1 ± 25.1£* 76.7 ± 31.8*Ŧ 79.9 ± 30.9*Ŧ
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Figure 1 Correlation between PTH (pg/mL) and 25OHD (nmol/L) in the sample studied. Above 75.0 nmol/L of 25OHD there is no
correlation with PTH.
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reported as Mean ± SD (Standard Deviation). Differences
were considered significant when p < 0.05.
Results
A total of 591 individuals were included as follows: NH,
177 individuals (128 women and 49 men, mean age 76.2 ±
9.0 years); CD, 243 individuals (168 women and 75 men,
mean age 79.6 ± 5.3 years); PA, 99 individuals (52 women
and 47 men, mean age 67.6 ± 5.4 years) and YOUNG, 72
individuals (40 women and 32 men, mean age 23.9 ±
2.8 years). In Tables 1, 2 and 3, only 25(OH)D measure-
ments done during winter were used for the group PA. In
relation to ethnicity, the sample was predominantly com-
posed of whites (84.4%).Table 2 Correlation between PTH (pg/mL) and 25(OH)D
(nmol/L) considering different 25(OH)D concentration
ranges
25(OH)D (nmol/L) n r p PTH (pg/mL)
All 572 −0.330 >0.001 62.6 ± 53.6
>25.0 460 −0.303 >0.001 58.0 ± 54.3
>37.5 373 −0.271 >0.001 51.9 ± 44.3
>50.0 292 −0.236 >0.001 47.2 ± 39.6
>62.5 205 −0.193 0.006 43.0 ± 35.6
>75.0 139 −0.137 0.114 39.4 ± 31.6
>87.5 93 −0.062 0.558 37.4 ± 26.5
>100.0 59 +0.138 0.306 36.4 ± 25.0The laboratory results obtained for the group as a total
and also separated by gender and subgroup of origin are
described in Table 1. Men presented higher creatinine,
creatinine clearance and 25(OH)D values, when com-
pared to women, but the sex ratio between groups dif-
fers significantly; there are more women in NH (72.3%)
and CD (69.1%) groups than in the PA (52.5%) and
YOUNG (55.5%) groups. We observed that people in
YOUNG group had a lower BMI and higher albumin
and creatinine clearance values when compared to the
other groups.
Only 6.3% of the total population studied had made use
of vitamin D supplements (dose varying from 200 to
400 IU a day) and these had a 25(OH)D average blood
concentration of 69.1 ± 34.9 nmol/L, while the group that
had not taken a vitamin D supplement showed a signifi-
cantly lower blood concentration (54.8 ± 33.4 nmol/L,
p = 0.018).
Using the Pearson´s linear correlation and considering
only individuals who were not using vitamin D supple-
ments, significant correlations were found between 25
(OH)D and age (r = −0.43, p = 0.001), PTH (r = −0.38,
p = 0.001), albumin (r = +0.32, p = 0.001), creatinine
clearence (r = +0.31, p = 0.001), ionized calcium (r = +0.30,
p = 0.001), month of the year (r = −0.29, p = 0.001) and
BMI (r = −0.21, p = 0.001). Creatinine did not show any
significant correlation (r = +0.04, p = 0.203). Using a model
of multiple linear regression, setting the age as the pre-
dictive variable and adjusting by ethnicity and gender,
the following correlations were still significant: PTH
Table 3 25(OH)D (nmol/L) and PTH (pg/mL) concentrations according to the different age groups (vitamin D users
were excluded), percentage of individuals with secondary hyperparathyroidism (SHP) within each group and
correlation between PTH and 25(OH)D evaluated by Pearson’s correlation
Age Group (years) n 25(OH)D (nmol/L) < 75.0 nmol/L (%) PTH (pg/mL) SHP (%) r p
17–35 72 86.3 ± 34.9 40.3 26.4 ± 15.4 6.9 −0.018 0.876
55–60 13 62.9 ± 35.7 64.2 50.8 ± 44.5 28.5 −0.185 0.546
61–70 97 60.9 ± 34.6 50.0 48.7 ± 46.3 25.0 −0.417 < 0.001
71–80 218 49.5 ± 28.4 84.8 68.3 ± 44.9 46.0 −0.309 < 0.001
81–90 132 43.8 ± 29.0 78.4 80.0 ± 71.2 52.5 −0.138 0.139
91–100 13 30.6 ± 17.2 100.0 123.4 ± 67.7 58.9 −0.398 0.225
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the year (p = 0.01).
Considering the PTH values, significant correlations
were found with the following variables: age (r = +0.37, p =
0.001), 25(OH)D (r = −0.38, p = 0.001), albumin (r = −0.30,
p = 0.001), creatinine clearence (r = −0.29, p = 0.001), cre-
atinine (r = +0.13, p = 0.003), ionized calcium (r = −0.25,
p = 0.001) and BMI (r = −0.13, p = 0.003). Using a model
of multiple linear regression, setting the age as the predict-
ive variable, 25(OH)D (p = 0.001), creatinine (p = 0.001)
and ionized calcium (p = 0.011) were still significant.
The mathematical equation which predicts the PTH
value, based on the 25(OH)D concentration is expressed
by the formula PTH = 10 + 104.24.e-(vitD-12.5)/62.36. We
also defined the concentration of 75.0 nmol/L as the
cut-off value for which 25(OH)D concentrations did not
correlate with PTH levels (Figure 1, Table 2). Within the
groups, 91.5% from NH; 87.6% from CD; 48.5% from PA
and 40.3% from YOUNG fell below this concentration
cut-off.
In Table 4 reports on the 25(OH)D concentration dis-
tribution (nmol/L) according to the group and season of
the year. Summer and fall were grouped together, con-
sidering these are very sunny. We observed that the NH
and CD groups were the ones showing the lowest 25Table 4 Mean ± standard deviation referring to the
comparisons of 25(OH)D according to the origin of the
sample and season of the year
Season of the year
Winter/Spring Summer/Fall
Origin n 25(OH)D (nmol/L) n 25(OH)D (nmol/L)
NH 111 36.1 ± 21.2 66 42.1 ± 25.9
CD 158 44.1 ± 24.0 85 59.1 ± 29.6 t
PA£ 99 78.9 ± 30.9 a b 88 91.6 ± 31.7 t a b
Young 35 69.3 ± 25.6 a b 37 103.6 ± 29.3 t a b
£ paired analysis.
t significant difference (p < 0.01) within each origin, considering the season of
the year.
a significant difference (p < 0.05) within each season of the year in relation
to NURSING.
b significant difference (p < 0.05) within each season of the year in relation
to COMMUNITY.(OH)D concentration throughout the year (36.1 ± 21.2
and 44.1 ± 24.0 nmol/L during winter/spring and 42.1 ±
25.9 and 59.1 ± 29.6 nmol/L during summer/fall, respect-
ively). The group NH was the only one not to show any
increase during summer/fall.
Within each age group, as age advances, progressively
lower 25(OH)D and higher PTH concentrations were
observed. 25OHD concentrations lower than 75.0 nmol/L
were found for 85.7% of those older than 71 years, while
the incidence of secondary hyperparathyroidism was 57%
among those (Table 3).
Discussion
Several reports have previously shown that the preva-
lence of hypovitaminosis D is high among the elderly in
the United States and Europe (< 30 ng/mL), but there
are few data from countries in South America, where
sunlight is abundant throughout the year, such as Brazil
[1-4]. The abundant sunlight would make us believe this
was a problem restricted to countries of higher latitudes.
However, Lips et al. and van der Wielen et al. demon-
strated that countries from southern Europe show
higher incidence of hypovitaminosis D when compared
to northern countries [1-5]. Some recent reviews showed
that the vitamin D deficiency is common in South Asia
and the Middle East [13,14].
The city of São Paulo is crossed by the Tropic of
Capricorn (23ºS) and presents relatively mild winters,
with temperatures rarely achieving 0°C (32°F). It is a
large urban center, being the largest one in South Amer-
ica, with a predominant Caucasian population. It has
more than 10 million inhabitants and a large concentra-
tion of high-rise buildings and industries. During winter
there is a significant concentration of air pollutants
which can absorb solar UVB radiation and, conse-
quently, reducing vitamin D formation [15]. Our elderly
population has been increased similar to the pattern of
developed countries. Between 1980 and 2003, there was
an increment of 8.7 years in the life expectancy at birth,
which nowadays is 71.3 years in Brazil.
Age was the variable that most significantly correlated
with 25(OH)D plasma concentrations, as was demonstrated
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had higher 25(OH)D concentrations (Table 3). For this rea-
son, in the multiple regression vitamin D status analysis, we
chose to use age as the predictive variable, adjusted by gen-
der and ethnicity. Among the other parameters evaluated
in the model, ionized calcium, PTH and month of the year,
which are other variables that present known correlation
with 25(OH)D, maintained significance [16,17].
It is known that the 25(OH)D plasma concentrations
follow a seasonal variation, demonstrated in places of
more temperate weather [16,18,19]. Our data clearly
demonstrate the existence of a seasonal pattern for 25
(OH)D concentrations throughout the year that follows
the ultraviolet radiation distribution and does not
change over time. This phenomenon was evident in all
the groups, except for the NH one (Table 4). In this
group, although the group age was similar to the one in
CD, the mean of the values in summer was not higher
than that obtained in winter. This suggests that sunlight
exposure was not enough for this group. On the other
hand, it was observed that the subjects from CD reached
values 34% higher in the summer, almost reaching the in-
crement rate observed for young people, which was 47%.
Gannagé-Yared et al. demonstrated that there are in-
fluences from life habits on 25(OH)D concentration (in
this study the use of veil was evaluated) [20]. Other
authors demonstrated that the seasonal variation also
exerts influences on bone remodeling markers, bone
mass and fractures [19,21]. In the same way, the individ-
uals from PA group demonstrated a well defined sea-
sonal variation when prospectively evaluated, except for
the ones older than 71 years old who presented a pattern
similar to that of the NH and CD groups [9]. An inter-
esting fact is that the group PA had some sunlight
exposure during their physical activities at least twice a
week for 1 h (in this group the use of sunscreen was
evaluated and no significant variation was found be-
tween users and non-users). These data suggest that if
more frequently exposed to sunlight, the individuals
younger than 70 years old can achieve an adequate vita-
min D status [22-24]. This is probably one of the advan-
tages of living in lower latitudes, where sunlight is more
abundant.
In our study, it was possible to observe the correlation
that exists between PTH and 25(OH)D, which was
expressed through an exponential equation (Figure 1),
the same way it has been described [20,25,26]. The con-
centration from which the correlation between 25(OH)D
and PTH was lost was > 75.0 nmol/L (Table 2), a value
similar to previous reports [27]. It means that above this
concentration, sufficiency of vitamin D does not inter-
fere with PTH secretion. We observed that the lower
concentrations of 25(OH)D are associated with second-
ary hyperparathyroidism and that was more frequent inNH and CD (Tables 1, 4 and 3). Among the young indi-
viduals evaluated in this study, we found a higher 25(OH)
D mean. However, for a good proportion of the samples
the values were below the sufficiency limit, but besides
that, no correlation with PTH was observed (r = −0.018,
p = 0.876). Among young individuals PTH does not
seem to be a good parameter to indirectly evaluate vita-
min D status [10].
For the multiple regression analysis, setting PTH level
as the depending variable and age as the adjusted predict-
ive variable, the evaluated parameters that maintained the
significance in the model were 25(OH)D, creatinine and
ionized calcium, variables which are known to exert influ-
ence on PTH levels [28,29]. Table 3 suggested that PTH
levels increased with age, possibly due to several factors
acting together, such as vitamin D insufficiency/deficiency,
renal function decrease (1α-hydroxylation) and the influ-
ence of prescription drugs on vitamin D metabolism
[29,30]. Another important factor is the decreased inges-
tion and intestinal absorption of calcium [31-33].
The primary objective of hypovitaminosis D correction is
promoting the maximum intestinal calcium absorption, re-
ducing the frequency of falls and correcting the secondary
hyperparathyroidism [27]. According to Bischoff-Ferrari
et al., the supplementation with at least 700 IU of vitamin
D/d was enough to reduce the risk of vertebral and non-
vertebral fractures [34]. Besides that, there are other non-
skeletal effects which have been attributed to vitamin D
status, such as the prevention of cancer and autoimmune
diseases [4]. In spite of all this knowledge, the number of
individuals who received vitamin D supplements was very
low. When the mean 25(OH)D concentration was evalu-
ated for this group, we observed that although it was higher
than the mean value for individuals who did not receive
supplementation, it was still below the ideal limit (73% of
these individuals presented concentrations < 75.0 nmol/L)
[3,4]. Therefore the vitamin D doses these individuals re-
ceived (200–400 IU/d) were not enough for the prevention
of hypovitaminosis D. The Endocrine Practice Guidelines
recommends adults need 1,500-2,000 IU vitamin D/d to
prevent vitamin D deficiency [35].
These results point out to the need for governmental
public health action, which could implement measures
such as vitamin D supplement distribution to nursing
homes, food supplementation and medical education
about the high prevalence of this condition among the
elderly, considering the associated risk for fractures.
Positive aspects of our paper include that we evaluated a
large number of adults from different populations col-
lected in the same city and analyzed by the same method.
It was possible to demonstrate that hypovitaminosis D is a
public health problem even in Brazil. However what is still
lacking is the relationship with vitamin D status with the
amount of sun exposure.
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population, it is always difficult to classify them ethnically.
Nevertheless, most of the evaluated individuals were white
(84.4%). According to the 2000 Brazilian Demographic
Census for the city of São Paulo, the white population is
the majority (67.0% of population, data from IBGE-
Instituto Brasileiro de Geografia e Estatística). However,
our data cannot be extrapolated to all different regions of
the country, because, besides different latitudes and wea-
ther conditions, the population presents different genetic
backgrounds and habits, which are important factors for
the serum vitamin D status.
In addition, several other factors potentially affect vita-
min D status such as genetic factors, adiposity, dietary
intake, intestinal malabsorption and impaired hydroxyl-
ation in the liver and kidneys.Conclusions
We found very low 25(OH)D concentrations for the elderly
when compared to younger people. This finding is possibly
due to age and habit-related sunlight exposure differences.
The existence of a seasonal variation over 25(OH)D con-
centrations is evident, as well as the influence of age is.
Secondary hyperparathyroidism was frequent among the
older individuals and was associated with 25(OH)D levels,
creatinine and ionized calcium. According to our data,
PTH values tend to plateau above 75.0 nmol/L. We found
that 73.3% of the sample population studied is below this
value.
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